MBM Wealth Consultants’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-56
Closed -$14K 108
2023
Q1
$14K Hold
56
0.01% 204
2022
Q4
$15K Hold
56
0.01% 206
2022
Q3
$13K Sell
56
-59
-51% -$14.3K 0.01% 201
2022
Q2
$28K Hold
115
0.01% 183
2022
Q1
$28K Hold
115
0.01% 207
2021
Q4
$26K Hold
115
0.01% 200
2021
Q3
$24K Hold
115
0.01% 198
2021
Q2
$28K Hold
115
0.01% 170
2021
Q1
$29K Hold
115
0.01% 165
2020
Q4
$26K Sell
115
-344
-75% -$79.3K 0.01% 159
2020
Q3
$117K Sell
459
-75
-14% -$18.6K 0.07% 94
2020
Q2
$126K Hold
534
0.09% 82
2020
Q1
$108K Hold
534
0.09% 83
2019
Q4
$129K Buy
534
+200
+60% +$44.1K 0.1% 87
2019
Q3
$65K Hold
334
0.05% 109
2019
Q2
$62K Hold
334
0.05% 114
2019
Q1
$63K Hold
334
0.06% 114
2018
Q4
$65K Buy
+334
New +$65.2K 0.06% 114

Other funds holding AMGN

MBM Wealth Consultants's AMGN Position: Q2 2023 in Review

MBM Wealth Consultants sold out of Amgen (AMGN) in Q2 2023, closing a stake of 56 shares — an estimated $14K sold.

MBM Wealth Consultants first reported a position in AMGN in Q4 2018 and held it in 18 quarters. The position peaked at $129K in Q4 2019. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • MBM Wealth Consultants reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • MBM Wealth Consultants sold 56 Amgen shares in Q2 2023, an estimated $14K.
  • MBM Wealth Consultants first reported a position in Amgen in Q4 2018 and held it in 18 quarters.
  • MBM Wealth Consultants's Amgen position peaked at $129K in Q4 2019.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on MBM Wealth Consultants's 13F filing for Q2 2023, filed 24 Jul 2023.